First Analysis Initiates Sharps Compliance With Overweight
Analysts at First Analysis initiated coverage on Sharps Compliance Corp. (NASDAQ: SMED) with a Overweight rating.
The target price for Sharps Compliance is set to $9.
Sharps Compliance shares have gained 49.34 percent over the past 52 weeks, while the S&P 500 index has surged 8.07 percent in the same period.
Sharps Compliance shares climbed 0.90 percent to close at $6.75 yesterday.
Latest Ratings for SMED
Date | Firm | Action | From | To |
---|---|---|---|---|
Apr 2021 | HC Wainwright & Co. | Maintains | Buy | |
Apr 2021 | Roth Capital | Maintains | Buy | |
Mar 2021 | Stifel | Maintains | Buy |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: First AnalysisInitiation Analyst Ratings